CMS updates Hospital Compare, seeks quality measures feedback

CMS is undergoing a revamp of its Compare websites, which allow patients and users to compare healthcare providers based on quality measures. The agency recently updated its Hospital Compare website with new measurement data and the Overall Hospital Quality Star Ratings.

CMS also recently announced it was planning to overhaul all the Medicare comparison tools into one combined portal that is easy to use and simple to navigate.

The agency announced last year it was planning to update the quality measurements of Hospital Compare, which would be reflected in the star ratings that rate hospitals on quality, with five stars being the best. The updated star ratings issued this week “use the existing methodology to ensure patients have the information they need,” CMS Administrator Seema Verma wrote in a blog post Jan. 29.

The agency asked for feedback on how to update the star ratings methodology via national quality conferences, listening sessions and soliciting advice from experts. The information received will inform methodology proposals planned to be issued in spring 2020 for the fiscal year 2021 Hospital Inpatient Prospective Payment System proposed rule.

Verma also noted the agency is still seeking feedback on the upcoming proposals and start ratings methodology.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup